SI

Sofinnova Investments Portfolio holdings

AUM $1.47B
1-Year Return 17.43%
This Quarter Return
+12.51%
1 Year Return
+17.43%
3 Year Return
+337.79%
5 Year Return
+424.38%
10 Year Return
–
AUM
$1.47B
AUM Growth
+$144M
Cap. Flow
+$51.7M
Cap. Flow %
3.52%
Top 10 Hldgs %
55.99%
Holding
73
New
9
Increased
18
Reduced
18
Closed
13

Top Buys

1
GILD icon
Gilead Sciences
GILD
$70M
2
ABBV icon
AbbVie
ABBV
$49.3M
3
BSX icon
Boston Scientific
BSX
$46.3M
4
LLY icon
Eli Lilly
LLY
$34.5M
5
UTHR icon
United Therapeutics
UTHR
$34.1M

Top Sells

1
SYK icon
Stryker
SYK
$111M
2
MDT icon
Medtronic
MDT
$50.6M
3
ALNY icon
Alnylam Pharmaceuticals
ALNY
$47.6M
4
BPMC
Blueprint Medicines
BPMC
$23.1M
5
BMY icon
Bristol-Myers Squibb
BMY
$22.7M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Shares
Change % 		Capital Flow
INZY
26
DELISTED
Inozyme Pharma
INZY
$17.1M 1.05%
4,280,308
– –
COGT icon
27
Cogent Biosciences
COGT
$1.82B
$16.9M 1.03%
2,355,505
+173,384
+8% +$1.24M
REPL icon
28
Replimune Group
REPL
$494M
$16.8M 1.03%
1,806,529
-673,410
-27% -$6.26M
RNA icon
29
Avidity Biosciences
RNA
$6.48B
$16.6M 1.02%
584,801
+204,870
+54% +$5.82M
SNDX icon
30
Syndax Pharmaceuticals
SNDX
$1.47B
$14.3M 0.87%
1,524,440
-750,783
-33% -$7.03M
CDTX icon
31
Cidara Therapeutics
CDTX
$1.6B
$12.2M 0.75%
+251,031
New +$12.2M
IMTX icon
32
Immatics
IMTX
$761M
$12.1M 0.74%
2,240,528
+686,224
+44% +$3.69M
EXAS icon
33
Exact Sciences
EXAS
$10.2B
$11.1M 0.68%
+208,300
New +$11.1M
PHVS icon
34
Pharvaris
PHVS
$1.48B
$10.3M 0.63%
585,532
-7,871
-1% -$139K
INBX icon
35
Inhibrx
INBX
$408M
$10.1M 0.62%
708,678
+10,762
+2% +$154K
RCUS icon
36
Arcus Biosciences
RCUS
$1.3B
$9.9M 0.61%
1,216,016
+178,240
+17% +$1.45M
YMAB icon
37
Y-mAbs Therapeutics
YMAB
$390M
$9.9M 0.61%
2,194,278
– –
AXSM icon
38
Axsome Therapeutics
AXSM
$6.25B
$9.77M 0.6%
93,610
-81,707
-47% -$8.53M
BIOA
39
BioAge Labs, Inc. Common Stock
BIOA
$171M
$9.52M 0.58%
2,304,901
– –
EWTX icon
40
Edgewise Therapeutics
EWTX
$1.64B
$9.4M 0.57%
716,873
+374,655
+109% +$4.91M
IMNM icon
41
Immunome
IMNM
$916M
$7.24M 0.44%
778,476
-10,190
-1% -$94.8K
DYN icon
42
Dyne Therapeutics
DYN
$2.02B
$5.85M 0.36%
614,865
-102,031
-14% -$971K
SVRA icon
43
Savara
SVRA
$643M
$5.6M 0.34%
2,457,352
-3,024,314
-55% -$6.9M
APGE icon
44
Apogee Therapeutics
APGE
$2.26B
$3.31M 0.2%
+76,180
New +$3.31M
NXTC icon
45
NextCure
NXTC
$13M
$1.23M 0.08%
222,655
– –
ESTA icon
46
Establishment Labs
ESTA
$1.13B
$1.2M 0.07%
28,120
-555
-2% -$23.7K
JBIO
47
Jade Biosciences, Inc. Common Stock
JBIO
$254M
$1.07M 0.07%
107,391
– –
MTSR
48
Metsera, Inc. Common Stock
MTSR
$3.77B
$1.03M 0.06%
36,191
-609
-2% -$17.3K
SRRK icon
49
Scholar Rock
SRRK
$3.02B
$937K 0.06%
26,440
-89,677
-77% -$3.18M
BOLT icon
50
Bolt Biotherapeutics
BOLT
$9.96M
$795K 0.05%
137,721
-1
-0% -$6
1
2
3